Results 201 to 210 of about 890,128 (333)

Interleukin‐6 as a Key Biomarker in Facioscapulohumeral Dystrophy: Evidence From Longitudinal Analyses

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini, Emanuela Martinuzzi, Sandra Dhifallah, Abderhmane Slioui, Angela Puma, Luisa Villa, Michele Cavalli, Andra Ezaru, Jérémy Garcia, Manuela Gambella, Federico Torre, Luca Jacopo Pavan, Nicolas Glaichenhaus, Sabrina Sacconi   +13 more
wiley   +1 more source

Effects of <i>Moringa oleifera</i> supplementation on immune and nutritional biomarkers in adults living with HIV: a systematic review and meta-analysis. [PDF]

Front Nutr
Jin D, Jin S, Zhou T, Sheng G, Gao P, Li G.   +5 more
europepmc   +1 more source

Primary Central Nervous System Lymphoma Mimicking Progressive Multifocal Leukoencephalopathy in a Patient with Acquired Immune Deficiency Syndrome

, 2014
Tomohiro Yamakawa, Katsuya Fujimoto, Ko Ebata, Junko Iwasaki, Shojiro Takahashi, Souichi Shiratori, Junichi Sugita, Takeshi Kondo, Mitsufumi Nishio, Takanori Teshima   +9 more
openalex   +2 more sources

Long survival in patients with acquired immune deficiency syndrome-related primary central nervous system lymphoma [PDF]

, 1994
Umberto Tirrelli, D. Errante, Emanuela Vaccher, Diego Serraino, Antonino Carbone, Marc C. Chamberlain   +5 more
openalex   +1 more source

CSF Levels of NPTX2 Are Associated With Less Brain Atrophy Over Time in Cognitively Unimpaired Individuals

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Neuronal pentraxin 2 (NPTX2) is a synaptic protein involved in synaptic plasticity and regulation of neuronal excitability. Lower baseline cerebrospinal fluid (CSF) NPTX2 levels have been shown to be associated with an earlier onset of mild cognitive impairment (MCI), a pre‐dementia syndrome, even after CSF Alzheimer's Disease (AD)
Juan P. Vazquez, Corinne Pettigrew, Yuxin Zhu, Claire Anderson, Guray Erus, Christos Davatzikos, Michael Miller, Abhay Moghekar, Sungtaek Oh, Chan‐Hyun Na, Marilyn Albert, Paul Worley, Anja Soldan   +12 more
wiley   +1 more source

Breakthroughs in immune checkpoint therapy: overcoming NSCLC immune checkpoint therapy resistance with novel techniques. [PDF]

Front Immunol
Kang LP, Huang HJ, Xu C, Chen HH, Huang DH, Jiang ZB.   +5 more
europepmc   +1 more source

Association between total immunoglobulin E and antibody responses to naturally acquired Ascaris lumbricoides infection and polymorphisms of immune system-related LIG4, TNFSF13B and IRS2 genes [PDF]

, 2009
Nathalie Acevedo, D. Mercado, Candelaria Vergara, Jorge Sánchez, Malcolm W. Kennedy, Silvia Jiménez, Antonio Fernandez, M.C. Gutiérrez, Leonardo Puerta, Luis Caraballo   +9 more
openalex   +1 more source

HAMPAO-SPECT of the brain and ocular microangiopathic syndrome in patients infected with the human immunodeficiency virus type 1 [PDF]

, 1993
Bogner, Johannes R., Einhäupl, Karl Max, Geier, Stephan A., Goebel, Frank-Detlef, Hammel, Gertrud, Sadri, Ifna, Schielke, Eva, Tatsch, Klaus   +7 more
core  

Decreased Serum 5‐HT: Clinical Correlates and Regulatory Role in NMJ of MG

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Although 5‐Hydroxytryptamine (5‐HT) indirectly stimulates muscle contraction and participates in regulating Acetylcholine receptor (AChR) cluster homeostasis in cellular, animal, and clinical studies, evidence regarding its potential to modulate muscle contraction in myasthenia gravis (MG) remains limited.
Xinru Shen, Jing Zhang, Xinyue Zhou, Xiaoxiao Yu, Haodong Shang, Shufan Chen, Lulu Zhen, Jinru Wu, Guanlian Hu, Xiaoyan Zhu, Zhan Sun, Yiren Wang, Jiahui Wang, Jie Lv, Xue Zhao, Yingna Zhang, Wei Guo, Ying Peng, Feng Gao   +18 more
wiley   +1 more source

Efficacy and safety of immune checkpoint inhibitor rechallenge therapy in the treatment of advanced acquired immune-resistant non-small cell lung cancer: a retrospective study. [PDF]

Front Oncol
Wang J, Gao Q, Chen J.
europepmc   +1 more source